LONG-TERM USE OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Begaj T, Jeong D, Park JG, Runner MM, Capone A Jr, Dass AB, Drenser KA, Faia LJ, Farley ND, Garretson BR, Hassan TS, Mahmoud TH, Margherio A, Raphaelian PV, Randhawa S, Ruby AJ, Sneed S, Rao P, Wolfe JD, Williams GA.
Begaj T, et al. Among authors: mahmoud th.
Retina. 2024 Feb 1;44(2):222-229. doi: 10.1097/IAE.0000000000003961.
Retina. 2024.
PMID: 37903288